Archived News and Events


Beginning January 1, 2018, OHIP+ (“OHIP-Plus”) will provide access and coverage to over 4, 400 drugs reimbursed under the Ontario Drug Benefit Program, including medications funde

PCC and TOCF Partnering to Improve Your Care

The Prescription Care Centre (PCC) and the Toronto Adult CF Program are partnering to improve the way you receive your medications, including specialty medications (e.g.

Infection control and hand hygiene updates

We have recently made updates to our infection control practices both in the clinic and on the ward.

Two Phase 3 Studies of the Tezacaftor/Ivacaftor Combination Leads to Improvements in Lung Function (FEV1) in People with Cystic Fibrosis

The research team at the Toronto Adult CF clinic would like  to share with the CF community the results of phase 3 clinical trials looking at the safety and efficacy of tezacaftor in combinati

Patient Education Needs Assessment

Your healthcare team at the Toronto Adult CF Clinic wants to know what CF-related topics you are interested in learning more about.

Inspirational stories

Here are some great stories of determination, perseverance and hard work...

Hand Hygiene

At the Toronto Adult CF Centre we are committed to infection control including Hand Hygiene.

New cystic fibrosis treatment approved by US FDA

The US Food and Drug Administration (FDA) approved Vertex’s new drug 

  • Read more
  • Dr. Elizabeth Tullis appointed to Cystic Fibrosis Canada Chair in Adult CF Research

    Our very own, Dr. Tullis has been appointed chair in adult CF research.